Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALIDATE: Valacyclovir in HIV/HSV-2 Coinfection
NCT00860977Phase 3Completed
- Sponsor
- University Health Network
- Start
- Mar 2010
- Primary completion
- Aug 2015
- Modality
- Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 3 trial of valaciclovir in human immunodeficiency virus infection (HIV), sponsored by University Health Network. Started Mar 2010; status: completed.
02
Drugs
valaciclovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00860977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860977.